Eiger BioPharma: 1Q Earnings Snapshot
PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $15.2 million in its first quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 62 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.
Eiger BioPharma shares have declined 37% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.44, a decline of 11% in the last 12 months.